Orion Healthcare Equity Partners logo

Orion Healthcare Equity Partners

North America, Massachusetts, United States, Boston

Description

Orion Healthcare Equity Management is a Venture Capital Firm focussed on health.

Investor Profile

Orion Healthcare Equity Partners has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Orion Healthcare Equity Partners frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
JDRF (The Juvenile Diabetes Research Foundation)
North America, New York, United States, New York
Co-Investments: 1
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 2
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Orion Healthcare Equity Partners often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Orion Healthcare Equity Partners?

AnTolRx

Cambridge, Massachusetts, United States

Our lead program addresses significant unmet needs in the field of Type 1 Diabetes

BiotechnologyHealth Care
Series ASep 8, 2016
Amount Raised: $4,000,000
Lysosomal Therapeutics

Cambridge, Massachusetts, United States

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

BiotechnologyHealth CareTherapeutics
Series AFeb 3, 2015
Amount Raised: $20,000,000
Lysosomal Therapeutics

Cambridge, Massachusetts, United States

Lysosomal Therapeutics deliver cures for neurodegenerative diseases.

BiotechnologyHealth CareTherapeutics
SeedMay 12, 2014
Amount Raised: $4,800,000